Robert J Marx, MD
General Practice · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 4 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
20 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Marx’s office at (408) 358-3511 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A30254 · Current
Licensed to practise in California · since 1976 · expires 2026-12-31 · Johns Hopkins University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$63,550
Medicare paid this office $63,550 for 163 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 153 | $31,871 | $72 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 99 | $15,573 | $157 |
| Return visit (30+ min) | 39 | $4,515 | $96 |
| Influenza vaccine split virus, preservative free | 43 | $3,518 | $82 |
| Administration of influenza virus vaccine | 43 | $1,680 | $39 |
See all 7 services
| Short return visit (20+ min) | 153 | $31,871 | $72 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 99 | $15,573 | $157 |
| Return visit (30+ min) | 39 | $4,515 | $96 |
| Influenza vaccine split virus, preservative free | 43 | $3,518 | $82 |
| Administration of influenza virus vaccine | 43 | $1,680 | $39 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 79 | $1,398 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 78 | $999 | $12 |
Who their Medicare patients are
163 Original Medicare patients in 2024. Average age 73 · Women 42% · Health risk score 0.76. At or below the middle of the specialty; the typical general practice clinician is at 1.33.
Conditions among them: High blood pressure 71% · Coronary heart disease 18% · Diabetes 17% · Chronic kidney disease 12% · Cancer 10% · Atrial fibrillation 10% · Depression 7%.
The office billed $123,878, Medicare allowed $81,794 and paid $63,550; for 908 services of 23 kinds; $3,660 of it was for drugs given in the office and $59,889 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 163 | 908 | 73 | 0.76 | $123,878 | $63,550 |
| 2023 | 158 | 911 | 73 | 0.68 | $112,520 | $62,358 |
| 2022 | 154 | 902 | 73 | 0.69 | $108,752 | $62,895 |
| 2021 | 166 | 867 | 73 | 0.67 | $98,468 | $59,011 |
| 2020 | 170 | 859 | 73 | 0.73 | $89,046 | $46,479 |
| 2019 | 170 | 826 | 74 | 0.76 | $82,203 | $43,260 |
| 2018 | 168 | 831 | 73 | 0.74 | $77,389 | $38,521 |
| 2017 | 159 | 828 | 73 | 0.86 | $69,873 | $34,897 |
| 2016 | 162 | 924 | 72 | 0.71 | $83,624 | $43,456 |
| 2015 | 167 | 1,053 | 72 | 0.71 | $99,298 | $53,198 |
| 2014 | 155 | 871 | 73 | 0.63 | $71,205 | $35,082 |
| 2013 | 151 | 744 | 73 | 0.60 | $58,245 | $30,091 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Short return visit (20+ min) | 146 | $28,441 | $69 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 83 | $12,940 | $156 |
| Return visit (30+ min) | 38 | $5,147 | $105 |
| Influenza vaccine split virus, preservative free | 55 | $3,953 | $72 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 13 | $2,567 | $197 |
| Administration of influenza virus vaccine | 55 | $2,033 | $37 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 97 | $1,716 | $18 |
| New patient visit (30+ min) | 18 | $1,248 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 89 | $1,042 | $11 |
2022: 10 services
| Short return visit (20+ min) | 141 | $25,582 | $68 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 89 | $14,111 | $159 |
| Influenza vaccine split virus, preservative free | 69 | $4,791 | $68 |
| Return visit (30+ min) | 32 | $4,609 | $107 |
| Administration of influenza virus vaccine | 69 | $2,608 | $37 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 12 | $2,409 | $201 |
| Pneumococcal vaccine, 23-valent | 12 | $1,595 | $133 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 87 | $1,551 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 82 | $915 | $11 |
| Administration of pneumococcal vaccine | 20 | $754 | $38 |
2021: 12 services
| Short return visit (20+ min) | 143 | $23,498 | $71 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 74 | $11,929 | $161 |
| Influenza vaccine split virus, preservative free | 73 | $4,764 | $65 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 17 | $3,450 | $203 |
| Return visit (30+ min) | 23 | $2,704 | $113 |
| Pneumococcal vaccine, 23-valent | 20 | $2,488 | $124 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 12 | $2,441 | $203 |
| Administration of influenza virus vaccine | 74 | $1,599 | $22 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 88 | $1,588 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 75 | $764 | $10 |
| Administration of pneumococcal vaccine | 29 | $623 | $21 |
| Urinalysis, manual test | 13 | $59 | $3 |
2020: 11 services
| Short return visit (20+ min) | 145 | $15,781 | $49 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 55 | $7,768 | $141 |
| Influenza vaccine split virus, preservative free | 94 | $5,726 | $61 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 19 | $3,931 | $207 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 15 | $3,004 | $200 |
| Pneumococcal vaccine, 13-valent | 13 | $2,913 | $224 |
| Administration of influenza virus vaccine | 95 | $1,988 | $21 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 89 | $1,596 | $18 |
| Return visit (30+ min) | 11 | $1,022 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 77 | $922 | $12 |
| Administration of pneumococcal vaccine | 19 | $396 | $21 |
2019: 12 services
| Short return visit (20+ min) | 140 | $16,341 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 61 | $8,145 | $134 |
| Influenza vaccine split virus, preservative free | 104 | $5,748 | $55 |
| Pneumococcal vaccine, 13-valent | 13 | $2,713 | $209 |
| Administration of influenza virus vaccine | 104 | $2,154 | $21 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $2,069 | $188 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 80 | $1,415 | $18 |
| Return visit (30+ min) | 12 | $1,280 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 48 | $624 | $13 |
| Short return visit | 15 | $547 | $30 |
| Administration of pneumococcal vaccine | 13 | $267 | $21 |
| Urinalysis, manual test | 11 | $44 | $3 |
2018: 9 services
| Short return visit (20+ min) | 133 | $15,551 | $52 |
| Influenza vaccine split virus, preservative free | 110 | $5,824 | $52 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 30 | $3,963 | $132 |
| Administration of influenza virus vaccine | 111 | $2,907 | $26 |
| Return visit (30+ min) | 17 | $1,654 | $83 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 75 | $1,444 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 61 | $709 | $12 |
| Short return visit | 22 | $703 | $31 |
| Urinalysis, manual test | 11 | $48 | $3 |
2017: 10 services
| Short return visit (20+ min) | 135 | $15,005 | $52 |
| Influenza vaccine split virus, preservative free | 117 | $5,968 | $47 |
| Administration of influenza virus vaccine | 116 | $4,036 | $32 |
| Pneumococcal vaccine, 13-valent | 16 | $2,964 | $185 |
| Return visit (30+ min) | 19 | $1,604 | $84 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 70 | $1,497 | $21 |
| Short return visit | 26 | $902 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 62 | $739 | $12 |
| Administration of pneumococcal vaccine | 16 | $517 | $32 |
| Urinalysis, manual test | 18 | $75 | $3 |
2016: 10 services
| Short return visit (20+ min) | 143 | $17,529 | $53 |
| Pneumococcal vaccine, 13-valent | 59 | $10,445 | $174 |
| Influenza vaccine split virus, preservative free | 103 | $4,168 | $39 |
| Administration of influenza virus vaccine | 108 | $3,516 | $32 |
| Administration of pneumococcal vaccine | 59 | $1,901 | $32 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 73 | $1,551 | $21 |
| Short return visit | 29 | $1,213 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 69 | $939 | $13 |
| Return visit (30+ min) | 11 | $826 | $69 |
| Urinalysis, manual test | 12 | $58 | $3 |
2015: 11 services
| Short return visit (20+ min) | 152 | $23,192 | $57 |
| Pneumococcal vaccine, 13-valent | 81 | $13,745 | $170 |
| Administration of influenza virus vaccine | 108 | $3,465 | $32 |
| Influenza vaccine split virus, preservative free | 93 | $3,264 | $35 |
| Administration of pneumococcal vaccine | 86 | $2,732 | $32 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 81 | $1,719 | $21 |
| Return visit (30+ min) | 12 | $1,297 | $93 |
| Short return visit | 20 | $979 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 68 | $897 | $13 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 16 | $284 | $18 |
| Urinalysis, manual test | 12 | $48 | $3 |
2014: 7 services
| Short return visit (20+ min) | 141 | $20,880 | $57 |
| Administration of influenza virus vaccine | 115 | $3,766 | $31 |
| Influenza vaccine split virus, preservative free | 92 | $2,996 | $33 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 72 | $1,531 | $21 |
| Short return visit | 32 | $1,129 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 68 | $857 | $12 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 20 | $352 | $18 |
2013: 10 services
| Short return visit (20+ min) | 132 | $18,147 | $56 |
| Administration of influenza virus vaccine | 83 | $2,736 | $32 |
| Influenza vaccine split virus, preservative free | 50 | $1,552 | $31 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 69 | $1,485 | $22 |
| Pneumococcal vaccine, 23-valent | 16 | $1,119 | $70 |
| Short return visit | 25 | $976 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 54 | $704 | $13 |
| Administration of pneumococcal vaccine | 16 | $516 | $32 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 33 | $403 | $12 |
| Urinalysis, manual test | 13 | $56 | $3 |
Drugs they prescribed that Part D paid
$31,708
Pharmacies billed $31,708 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,206 generic and fewer than 11 brand-name prescriptions · $31,708 in drug cost · 62 antibiotic prescriptions to 45 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 212 | $1,646 | $8 |
| Levothyroxine | 93 | $1,021 | $11 |
| Losartan | 102 | $795 | $8 |
| Benazepril | 97 | $786 | $8 |
| Amlodipine Besylate | 93 | $723 | $8 |
See all 23 drugs
| Atorvastatin | 212 | $1,646 | $8 |
| Levothyroxine | 93 | $1,021 | $11 |
| Losartan | 102 | $795 | $8 |
| Benazepril | 97 | $786 | $8 |
| Amlodipine Besylate | 93 | $723 | $8 |
| Losartan-Hydrochlorothiazide | 29 | $538 | $19 |
| Tamsulosin | 20 | $418 | $21 |
| Rosuvastatin | 43 | $372 | $9 |
| Omeprazole | 22 | $315 | $14 |
| Fluoxetine | 18 | $313 | $17 |
| Fluticasone Propionate | 16 | $287 | $18 |
| Albuterol Sulfate Hfa | 12 | $261 | $22 |
| Acyclovir | 19 | $233 | $12 |
| Simvastatin | 32 | $219 | $7 |
| Metformin | 31 | $209 | $7 |
| Hydrochlorothiazide | 54 | $200 | $4 |
| Metoprolol | 22 | $175 | $8 |
| Allopurinol | 23 | $145 | $6 |
| Azithromycin | 30 | $135 | $5 |
| Bupropion Xl | 15 | $122 | $8 |
| Amoxicillin-Clavulanate Potass | 13 | $104 | $8 |
| Atenolol | 17 | $66 | $4 |
| Citalopram Hbr | 15 | $26 | $2 |
Year by year
| 2024 | 1,291 | 163 | None | None | $31,708 |
| 2023 | 1,320 | 156 | None | None | $51,590 |
| 2022 | 1,187 | 162 | 0% (0) | 10% | $40,869 |
| 2021 | 1,270 | 161 | 0% (0) | 8% | $42,603 |
| 2020 | 1,289 | 150 | None | 10% | $53,352 |
| 2019 | 1,316 | 144 | None | 8% | $50,390 |
| 2018 | 1,399 | 143 | None | 10% | $48,780 |
| 2017 | 1,403 | 141 | None | 13% | $57,262 |
| 2016 | 1,608 | 148 | None | 13% | $61,693 |
| 2015 | 1,583 | 135 | None | 13% | $50,910 |
| 2014 | 1,542 | 123 | None | 16% | $50,639 |
| 2013 | 1,194 | 97 | 2% (22) | 16% | $38,623 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Janumet | 11 | $14,295 | $1,300 |
| Atorvastatin | 189 | $1,930 | $10 |
| Levothyroxine | 97 | $1,880 | $19 |
| Losartan | 99 | $1,240 | $13 |
| Benazepril | 84 | $1,151 | $14 |
| Losartan-Hydrochlorothiazide | 37 | $743 | $20 |
| Amlodipine Besylate | 103 | $558 | $5 |
| Rosuvastatin | 45 | $533 | $12 |
| Omeprazole | 24 | $419 | $17 |
| Metformin | 33 | $410 | $12 |
| Fluticasone Propionate | 21 | $367 | $17 |
| Metoprolol | 24 | $339 | $14 |
| Simvastatin | 47 | $295 | $6 |
| Bupropion Xl | 18 | $293 | $16 |
| Allopurinol | 23 | $290 | $13 |
| Pantoprazole | 22 | $258 | $12 |
| Fluoxetine | 20 | $254 | $13 |
| Pravastatin | 17 | $241 | $14 |
| Hydrochlorothiazide | 38 | $194 | $5 |
| Acyclovir | 15 | $194 | $13 |
| Atenolol | 18 | $168 | $9 |
| Citalopram Hbr | 22 | $150 | $7 |
| Trazodone | 12 | $135 | $11 |
| Azithromycin | 26 | $128 | $5 |
| Tamsulosin | 11 | $122 | $11 |
| Gabapentin | 11 | $78 | $7 |
| Naproxen | 12 | $53 | $4 |
2022: 27 drugs
| Atorvastatin | 162 | $1,894 | $12 |
| Levothyroxine | 107 | $1,491 | $14 |
| Benazepril | 92 | $1,272 | $14 |
| Losartan | 68 | $919 | $14 |
| Benazepril-Hydrochlorothiazide | 12 | $835 | $70 |
| Omeprazole | 29 | $523 | $18 |
| Olmesartan Medoxomil | 19 | $454 | $24 |
| Tamsulosin | 22 | $450 | $20 |
| Amlodipine Besylate | 82 | $398 | $5 |
| Losartan-Hydrochlorothiazide | 20 | $371 | $19 |
| Rosuvastatin | 27 | $360 | $13 |
| Metoprolol | 25 | $343 | $14 |
| Simvastatin | 46 | $327 | $7 |
| Allopurinol | 27 | $293 | $11 |
| Metformin | 28 | $280 | $10 |
| Fluticasone Propionate | 17 | $275 | $16 |
| Trazodone | 15 | $227 | $15 |
| Valsartan | 17 | $195 | $11 |
| Pravastatin | 16 | $191 | $12 |
| Paxlovid (Eua) | 13 | $137 | $11 |
| Citalopram Hbr | 17 | $124 | $7 |
| Hydrochlorothiazide | 45 | $109 | $2 |
| Naproxen | 16 | $87 | $5 |
| Azithromycin | 14 | $80 | $6 |
| Atenolol | 17 | $64 | $4 |
| Lisinopril | 13 | $39 | $3 |
| Euthyrox | 16 | $21 | $1 |
2021: 29 drugs
| Flovent Hfa | 11 | $8,057 | $732 |
| Levothyroxine | 104 | $2,215 | $21 |
| Atorvastatin | 166 | $2,085 | $13 |
| Benazepril-Hydrochlorothiazide | 23 | $1,357 | $59 |
| Losartan | 110 | $1,329 | $12 |
| Benazepril | 98 | $1,047 | $11 |
| Valsartan | 15 | $1,041 | $69 |
| Rosuvastatin | 40 | $992 | $25 |
| Fluticasone Propionate | 22 | $712 | $32 |
| Metoprolol | 27 | $675 | $25 |
| Omeprazole | 36 | $565 | $16 |
| Losartan-Hydrochlorothiazide | 15 | $546 | $36 |
| Pravastatin | 14 | $541 | $39 |
| Amlodipine Besylate | 76 | $462 | $6 |
| Tamsulosin | 21 | $451 | $21 |
| Olmesartan Medoxomil | 12 | $427 | $36 |
| Simvastatin | 47 | $356 | $8 |
| Allopurinol | 23 | $343 | $15 |
| Hydrochlorothiazide | 49 | $335 | $7 |
| Bisoprolol-Hydrochlorothiazide | 12 | $256 | $21 |
| Metformin | 29 | $233 | $8 |
| Acyclovir | 14 | $193 | $14 |
| Trazodone | 20 | $173 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $155 | $14 |
| Atenolol | 28 | $152 | $5 |
| Triamcinolone Acetonide | 11 | $136 | $12 |
| Citalopram Hbr | 20 | $121 | $6 |
| Sildenafil Citrate | 11 | $75 | $7 |
| Naproxen | 14 | $60 | $4 |
2020: 24 drugs
| Janumet | 20 | $13,873 | $694 |
| Atorvastatin | 152 | $2,364 | $16 |
| Levothyroxine | 87 | $2,041 | $23 |
| Losartan-Hydrochlorothiazide | 18 | $1,718 | $95 |
| Losartan | 112 | $1,531 | $14 |
| Olmesartan Medoxomil | 16 | $1,467 | $92 |
| Metoprolol | 39 | $1,316 | $34 |
| Benazepril-Hydrochlorothiazide | 17 | $1,157 | $68 |
| Benazepril | 79 | $1,092 | $14 |
| Rosuvastatin | 33 | $1,075 | $33 |
| Valsartan | 14 | $845 | $60 |
| Simvastatin | 63 | $713 | $11 |
| Fluticasone Propionate | 27 | $687 | $25 |
| Hydrochlorothiazide | 86 | $623 | $7 |
| Omeprazole | 35 | $588 | $17 |
| Amlodipine Besylate | 76 | $525 | $7 |
| Allopurinol | 30 | $416 | $14 |
| Bisoprolol-Hydrochlorothiazide | 14 | $381 | $27 |
| Pravastatin | 14 | $313 | $22 |
| Metformin | 22 | $274 | $12 |
| Tamsulosin | 19 | $251 | $13 |
| Atenolol | 19 | $215 | $11 |
| Acyclovir | 14 | $182 | $13 |
| Citalopram Hbr | 17 | $69 | $4 |
2019: 27 drugs
| Janumet | 17 | $10,860 | $639 |
| Atorvastatin | 149 | $2,506 | $17 |
| Levothyroxine | 89 | $2,032 | $23 |
| Losartan | 124 | $1,525 | $12 |
| Rosuvastatin | 14 | $1,268 | $91 |
| Benazepril | 103 | $1,096 | $11 |
| Metoprolol | 45 | $1,023 | $23 |
| Olmesartan Medoxomil | 25 | $978 | $39 |
| Simvastatin | 74 | $834 | $11 |
| Valacyclovir | 18 | $750 | $42 |
| Fluticasone Propionate | 37 | $583 | $16 |
| Amlodipine Besylate | 89 | $575 | $6 |
| Omeprazole | 30 | $506 | $17 |
| Pravastatin | 22 | $464 | $21 |
| Hydrochlorothiazide | 62 | $378 | $6 |
| Losartan-Hydrochlorothiazide | 18 | $370 | $21 |
| Allopurinol | 18 | $230 | $13 |
| Pantoprazole | 11 | $204 | $19 |
| Atenolol | 11 | $163 | $15 |
| Metformin | 16 | $152 | $9 |
| Acyclovir | 16 | $134 | $8 |
| Azithromycin | 16 | $120 | $7 |
| Naproxen | 14 | $107 | $8 |
| Triamcinolone Acetonide | 11 | $82 | $7 |
| Valsartan-Hydrochlorothiazide | 14 | $47 | $3 |
| Citalopram Hbr | 12 | $43 | $4 |
| Zolpidem | 11 | $34 | $3 |
2018: 31 drugs
| Janumet | 21 | $10,245 | $488 |
| Atorvastatin | 161 | $2,955 | $18 |
| Rosuvastatin | 11 | $1,779 | $162 |
| Olmesartan Medoxomil | 15 | $1,767 | $118 |
| Levothyroxine | 100 | $1,761 | $18 |
| Metoprolol | 37 | $1,423 | $38 |
| Benazepril | 99 | $897 | $9 |
| Losartan | 103 | $842 | $8 |
| Valsartan | 27 | $790 | $29 |
| Simvastatin | 90 | $764 | $8 |
| Pravastatin | 24 | $723 | $30 |
| Amlodipine Besylate | 96 | $666 | $7 |
| Omeprazole | 29 | $575 | $20 |
| Fluticasone Propionate | 28 | $457 | $16 |
| Losartan-Hydrochlorothiazide | 30 | $414 | $14 |
| Tamsulosin | 13 | $382 | $29 |
| Metformin | 28 | $288 | $10 |
| Hydrochlorothiazide | 45 | $278 | $6 |
| Lovastatin | 16 | $265 | $17 |
| Allopurinol | 13 | $178 | $14 |
| Atenolol | 17 | $154 | $9 |
| Valacyclovir | 12 | $139 | $12 |
| Triamcinolone Acetonide | 11 | $138 | $13 |
| Azithromycin | 23 | $135 | $6 |
| Pantoprazole | 16 | $132 | $8 |
| Trazodone | 22 | $124 | $6 |
| Valsartan-Hydrochlorothiazide | 13 | $112 | $9 |
| Triamterene-Hydrochlorothiazid | 11 | $110 | $10 |
| Fluoxetine | 12 | $101 | $8 |
| Zolpidem | 16 | $96 | $6 |
| Citalopram Hbr | 11 | $50 | $5 |
2017: 33 drugs
| Janumet | 31 | $16,541 | $534 |
| Atorvastatin | 150 | $2,718 | $18 |
| Levothyroxine | 99 | $1,961 | $20 |
| Metoprolol | 28 | $1,105 | $39 |
| Rosuvastatin | 11 | $1,087 | $99 |
| Benazepril-Hydrochlorothiazide | 18 | $938 | $52 |
| Simvastatin | 87 | $753 | $9 |
| Synthroid | 16 | $737 | $46 |
| Benazepril | 92 | $644 | $7 |
| Losartan | 71 | $625 | $9 |
| Valsartan | 25 | $607 | $24 |
| Tamsulosin | 12 | $571 | $48 |
| Pravastatin | 26 | $532 | $20 |
| Amlodipine Besylate | 93 | $514 | $6 |
| Losartan-Hydrochlorothiazide | 40 | $379 | $9 |
| Pantoprazole | 24 | $348 | $15 |
| Fluticasone Propionate | 16 | $337 | $21 |
| Omeprazole | 23 | $268 | $12 |
| Metformin | 33 | $259 | $8 |
| Hydrochlorothiazide | 44 | $243 | $6 |
| Lovastatin | 25 | $234 | $9 |
| Naproxen | 24 | $215 | $9 |
| Amoxicillin-Clavulanate Potass | 12 | $180 | $15 |
| Zolpidem | 22 | $174 | $8 |
| Allopurinol | 20 | $150 | $8 |
| Triamcinolone Acetonide | 12 | $133 | $11 |
| Azithromycin | 18 | $133 | $7 |
| Fluoxetine | 16 | $117 | $7 |
| Trazodone | 21 | $112 | $5 |
| Cephalexin | 11 | $109 | $10 |
| Atenolol | 22 | $107 | $5 |
| Lisinopril | 13 | $76 | $6 |
| Citalopram Hbr | 12 | $66 | $6 |
2016: 36 drugs
| Janumet | 19 | $9,438 | $497 |
| Crestor | 11 | $3,197 | $291 |
| Atorvastatin | 173 | $2,889 | $17 |
| Levothyroxine | 91 | $1,852 | $20 |
| Synthroid | 34 | $1,485 | $44 |
| Benazepril-Hydrochlorothiazide | 27 | $1,362 | $50 |
| Metoprolol | 28 | $966 | $34 |
| Losartan | 105 | $954 | $9 |
| Simvastatin | 108 | $946 | $9 |
| Rosuvastatin | 11 | $909 | $83 |
| Pravastatin | 26 | $778 | $30 |
| Omeprazole | 48 | $643 | $13 |
| Benazepril | 70 | $545 | $8 |
| Tamsulosin | 23 | $510 | $22 |
| Amlodipine Besylate | 69 | $433 | $6 |
| Metformin | 42 | $393 | $9 |
| Fluticasone Propionate | 30 | $364 | $12 |
| Hydrochlorothiazide | 55 | $340 | $6 |
| Naproxen | 36 | $333 | $9 |
| Pantoprazole | 28 | $305 | $11 |
| Triamcinolone Acetonide | 31 | $288 | $9 |
| Baclofen | 12 | $280 | $23 |
| Losartan-Hydrochlorothiazide | 30 | $263 | $9 |
| Gabapentin | 13 | $257 | $20 |
| Lovastatin | 26 | $254 | $10 |
| Quinapril | 11 | $235 | $21 |
| Zolpidem | 15 | $225 | $15 |
| Fluoxetine | 14 | $210 | $15 |
| Amoxicillin-Clavulanate Potass | 14 | $184 | $13 |
| Valacyclovir | 13 | $163 | $13 |
| Atenolol | 35 | $147 | $4 |
| Trazodone | 17 | $142 | $8 |
| Azithromycin | 19 | $126 | $7 |
| Ciprofloxacin | 12 | $93 | $8 |
| Metoprolol | 16 | $44 | $3 |
| Meloxicam | 11 | $21 | $2 |
2015: 32 drugs
| Crestor | 14 | $5,099 | $364 |
| Atorvastatin | 156 | $2,547 | $16 |
| Levothyroxine | 94 | $2,264 | $24 |
| Metoprolol | 43 | $1,410 | $33 |
| Synthroid | 25 | $1,261 | $50 |
| Benazepril-Hydrochlorothiazide | 28 | $1,230 | $44 |
| Pravastatin | 44 | $1,133 | $26 |
| Valsartan | 13 | $1,005 | $77 |
| Tamsulosin | 45 | $938 | $21 |
| Losartan | 86 | $829 | $10 |
| Clotrimazole-Betamethasone | 11 | $829 | $75 |
| Simvastatin | 97 | $799 | $8 |
| Omeprazole | 48 | $679 | $14 |
| Benazepril | 86 | $517 | $6 |
| Hydrochlorothiazide | 71 | $509 | $7 |
| Propranolol | 16 | $452 | $28 |
| Losartan-Hydrochlorothiazide | 35 | $387 | $11 |
| Amlodipine Besylate | 73 | $376 | $5 |
| Pantoprazole | 25 | $360 | $14 |
| Amoxicillin-Clavulanate Potass | 15 | $325 | $22 |
| Metformin | 62 | $321 | $5 |
| Lovastatin | 26 | $306 | $12 |
| Fluticasone Propionate | 27 | $304 | $11 |
| Zolpidem | 20 | $284 | $14 |
| Quinapril | 12 | $280 | $23 |
| Naproxen | 24 | $224 | $9 |
| Atenolol | 28 | $134 | $5 |
| Trazodone | 23 | $124 | $5 |
| Triamcinolone Acetonide | 13 | $108 | $8 |
| Metoprolol | 13 | $98 | $8 |
| Azithromycin | 15 | $94 | $6 |
| Glimepiride | 16 | $73 | $5 |
2014: 33 drugs
| Crestor | 15 | $4,897 | $326 |
| Atorvastatin | 141 | $3,602 | $26 |
| Voltaren | 16 | $2,373 | $148 |
| Metoprolol | 41 | $1,695 | $41 |
| Levothyroxine | 76 | $1,550 | $20 |
| Etodolac | 16 | $1,465 | $92 |
| Synthroid | 29 | $1,172 | $40 |
| Pravastatin | 46 | $1,148 | $25 |
| Benazepril-Hydrochlorothiazide | 16 | $1,130 | $71 |
| Simvastatin | 115 | $1,125 | $10 |
| Benazepril | 114 | $1,095 | $10 |
| Losartan | 81 | $993 | $12 |
| Omeprazole | 45 | $856 | $19 |
| Tamsulosin | 42 | $648 | $15 |
| Losartan-Hydrochlorothiazide | 38 | $628 | $17 |
| Amlodipine Besylate | 76 | $562 | $7 |
| Hydrochlorothiazide | 57 | $491 | $9 |
| Fluticasone Propionate | 30 | $393 | $13 |
| Pantoprazole | 23 | $373 | $16 |
| Metformin | 51 | $360 | $7 |
| Triamcinolone Acetonide | 11 | $329 | $30 |
| Quinapril | 11 | $290 | $26 |
| Lovastatin | 21 | $251 | $12 |
| Nifedipine Er | 12 | $245 | $20 |
| Naproxen | 21 | $230 | $11 |
| Propranolol | 16 | $185 | $12 |
| Atenolol | 32 | $180 | $6 |
| Zolpidem | 23 | $168 | $7 |
| Azithromycin | 17 | $138 | $8 |
| Trazodone | 14 | $80 | $6 |
| Lorazepam | 12 | $55 | $5 |
| Citalopram Hbr | 12 | $52 | $4 |
| Metoprolol | 13 | $50 | $4 |
2013: 29 drugs
| Crestor | 16 | $3,943 | $246 |
| Atorvastatin | 103 | $3,202 | $31 |
| Janumet | 11 | $2,838 | $258 |
| Losartan | 53 | $1,551 | $29 |
| Metoprolol | 45 | $1,423 | $32 |
| Simvastatin | 102 | $1,377 | $13 |
| Clotrimazole-Betamethasone | 21 | $1,314 | $63 |
| Pravastatin | 56 | $1,133 | $20 |
| Omeprazole | 35 | $1,120 | $32 |
| Benazepril | 68 | $799 | $12 |
| Fluticasone Propionate | 35 | $762 | $22 |
| Levothyroxine | 45 | $636 | $14 |
| Amlodipine Besylate | 52 | $493 | $9 |
| Losartan-Hydrochlorothiazide | 29 | $444 | $15 |
| Tamsulosin | 21 | $443 | $21 |
| Metformin | 46 | $369 | $8 |
| Nifedipine Er | 12 | $362 | $30 |
| Hydrochlorothiazide | 35 | $319 | $9 |
| Benazepril-Hydrochlorothiazide | 12 | $316 | $26 |
| Lovastatin | 20 | $279 | $14 |
| Azithromycin | 17 | $199 | $12 |
| Hydrocodone-Acetaminophen | 16 | $196 | $12 |
| Propranolol | 16 | $153 | $10 |
| Zolpidem | 23 | $147 | $6 |
| Quinapril | 11 | $139 | $13 |
| Atenolol | 17 | $105 | $6 |
| Lisinopril | 16 | $102 | $6 |
| Naproxen | 12 | $64 | $5 |
| Lorazepam | 12 | $49 | $4 |
Money from drug and device companies
$647 in 2025
| 2025 | 3 | 6 | None | $647 |
| 2024 | 1 | 6 | None | $649 |
| 2023 | 1 | 4 | None | $488 |
| 2022 | 3 | 6 | None | $549 |
| 2021 | 4 | 6 | None | $738 |
| 2020 | 1 | 1 | None | $21 |
| 2019 | 1 | 3 | None | $256 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Breztri | $497 | 4 payments
|
| Lilly USA | Jardiance | $125 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $25 | 1 payment
|
See all 6 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-11 | Breztri | $125 |
| Exact Sciences | Meals · 2025-07-23 | Cologuard Collection Kit | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-04 | Airsupra | $124 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-08 | Breztri | $125 |
| Lilly USA | Meals · 2025-04-10 | Jardiance | $125 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-26 | Farxiga | $124 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $649
| AstraZeneca Pharmaceuticals LP | Farxiga | $649 | 6 payments
|
2023: $488
| AstraZeneca Pharmaceuticals LP | Breztri | $488 | 4 payments
|
2022: $549
| AstraZeneca Pharmaceuticals LP | Farxiga | $272 | 3 payments
|
| Abbvie | Ubrelvy | $153 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $125 | 1 payment
|
2021: $738
| AbbVie | Ubrelvy | $248 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $245 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $125 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $120 | 1 payment
|
2020: $21
| AstraZeneca Pharmaceuticals LP | Farxiga | $21 | 1 payment
|
2019: $256
| AstraZeneca Pharmaceuticals LP | Farxiga | $256 | 3 payments
|
Professional record
- NPI
- 1073576351
- Licence
- CA A30254California A30254: Current · expires 2026-12-31
- Trained
- Johns Hopkins University School of Medicine, 1975
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- General practice (208D00000X)
- Mailing address
- 14911 National Ave, Suite # 7, Los Gatos, CA, 95032
- NPI first listed
- 2006-04-08
- NPI last updated
- 2010-08-31
This is when the NPI record was last certified, not a medical board exam.